- Home
- ACTU vs AFCG Comparison
ACTU vs AFCG Comparison
Compare ACTU & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- AFCG
- Stock Information
- Founded
- ACTU 2015
- AFCG 2020
- Country
- ACTU United States
- AFCG United States
- Employees
- ACTU N/A
- AFCG N/A
- Industry
- ACTU
- AFCG Real Estate Investment Trusts
- Sector
- ACTU
- AFCG Real Estate
- Exchange
- ACTU NYSE
- AFCG Nasdaq
- Market Cap
- ACTU 162.1M
- AFCG 189.9M
- IPO Year
- ACTU 2024
- AFCG 2021
- Fundamental
- Price
- ACTU $7.69
- AFCG $7.91
- Analyst Decision
- ACTU
- AFCG Buy
- Analyst Count
- ACTU 0
- AFCG 6
- Target Price
- ACTU N/A
- AFCG $12.00
- AVG Volume (30 Days)
- ACTU 20.8K
- AFCG 170.0K
- Earning Date
- ACTU 03-04-2025
- AFCG 03-13-2025
- Dividend Yield
- ACTU N/A
- AFCG 19.86%
- EPS Growth
- ACTU N/A
- AFCG N/A
- EPS
- ACTU N/A
- AFCG 0.40
- Revenue
- ACTU N/A
- AFCG $43,164,939.00
- Revenue This Year
- ACTU N/A
- AFCG N/A
- Revenue Next Year
- ACTU N/A
- AFCG N/A
- P/E Ratio
- ACTU N/A
- AFCG $30.83
- Revenue Growth
- ACTU N/A
- AFCG N/A
- 52 Week Low
- ACTU $5.51
- AFCG $7.45
- 52 Week High
- ACTU $11.73
- AFCG $10.88
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- AFCG 31.84
- Support Level
- ACTU N/A
- AFCG $8.06
- Resistance Level
- ACTU N/A
- AFCG $8.88
- Average True Range (ATR)
- ACTU 0.00
- AFCG 0.22
- MACD
- ACTU 0.00
- AFCG -0.00
- Stochastic Oscillator
- ACTU 0.00
- AFCG 10.19
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to state-law-compliant cannabis operators in the U.S. Through the management team's deep network and significant credit and cannabis expertise, AFC originates, structures and underwrites loans ranging from $10 million to over $100 million, typically secured by quality real estate assets, license value and cash flows.